![]() | |
Clinical data | |
---|---|
Other names | ORG-30659; Exogestin; Letogestin;[1] 11-Methylene-δ15-norethisterone; 17α-Ethynyl-11-methylene-19-nor-δ15-testosterone |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C21H24O2 |
Molar mass | 308.421 g·mol−1 |
3D model (JSmol) | |
| |
|
Tosagestin (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name) (developmental code nameORG-30659), also known as11-methylene-δ15-norethisterone or17α-ethynyl-11-methylene-19-nor-δ15-testosterone, is aprogestin of the19-nortestosterone group which was under development byOrganon in theUnited States andEurope as ahormonal contraceptive (in combination withethinylestradiol) and for the treatment ofmenopausal symptoms but was never marketed.[2][3][4][5][6]
![]() | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |